A hypodermic needle is a critical interface between the injectable drug product, the healthcare professional, and the patient. Although often perceived as a simple accessory, the needle directly influences patient safety and comfort, treatment efficacy, usability, and protection of healthcare professionals during preparation and administration. Because the needle penetrates the targeted tissue and determines how the drug is delivered, its selection should be considered an integral part of the overall therapy value proposition rather than a late-stage component choice.
Hypodermic needles are defined by multiple technical attributes, including gauge and cannula diameter, needle length, wall thickness, bevel and point type, coating, dead space, hub material, safety mechanism, primary and secondary packaging format, sterilization approach, and compatibility with syringes or other delivery systems. Each attribute must be assessed against the specific requirements of the drug and its intended use. Key considerations include drug viscosity, dose volume, formulation sensitivity, administration route, injection site, patient profile, frequency of use, healthcare setting, and regional market expectations.
When needles are co-packed with a pharmaceutical product, additional requirements emerge. The needle must fit the drug manufacturer’s packaging process, support supply-chain efficiency, meet regulatory and quality expectations, and reinforce the intended user experience at the point of care. Co-packing can also help pharmaceutical companies secure product differentiation, reduce variability in clinical practice, simplify ordering and preparation, and strengthen the perceived completeness of the therapy solution.
This presentation will provide practical guidelines for selecting hypodermic needles for co-packaged drug products. It will identify the most relevant needle attributes, explain how these attributes should be matched to application requirements, and highlight how an optimized co-pack strategy can protect and enhance the value proposition of injectable therapies.
Most registrants disappear after the session ends. We help you
open the right doors before, during, and after the webinar.
<span>By ticking this box, you consent to receiving communications from Terumo Medical Care Solutions related to this topic and other products or services within their portfolio</span>